神経科学の抗体とアッセイの世界市場 2024-2028

概要

神経科学の抗体とアッセイ市場は2023-2028年に22億米ドル、予測期間中のCAGRは9.64%で成長すると予測されます。

当レポートでは、神経科学の抗体とアッセイ市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経疾患の増加、政府やヘルスケア機関からの取り組みや支援の増加、抗体製造の技術進歩などが市場を牽引しています。

本調査では、臨床試験の増加が今後数年間の神経科学の抗体とアッセイ市場成長を促進する主な要因の1つであるとしています。また、リキッドバイオプシーの出現やシングルセル解析技術の導入が増加していることも、市場の大きな需要につながっています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 神経科学の抗体とアッセイの世界市場 2018-2022
• タイプセグメント分析 2018-2022
• 用途別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 消耗品：市場規模と予測 2023-2028
• 器具：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 製薬会社およびバイオ医薬品会社：市場規模と予測 2023-2028
• 学術研究機関：市場規模と予測 2023-2028
• 病院と診断センター：市場規模と予測 2023-2028
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abcam plc
• Abnova Corp.
• Bio Rad Laboratories Inc.
• BMG LABTECH GmbH
• Cell Signaling Technology Inc.
• Chemie Brunschwig AG
• Elabscience Biotechnology Inc.
• F. Hoffmann La Roche Ltd.
• Fujirebio Holdings Inc.
• GenScript Biotech Corp.
• Merck KGaA
• PerkinElmer Inc.
• Rockland Immunochemicals Inc.
• Santa Cruz Biotechnology Inc.
• Thermo Fisher Scientific Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global neuroscience antibodies and assays market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Consumables - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Instruments - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Instruments - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ billion)
• Exhibits43: Data Table on Market opportunity by Type ($ billion)
• Exhibits44: Chart on Application - Market share 2023-2028 (%)
• Exhibits45: Data Table on Application - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Application
• Exhibits47: Data Table on Comparison by Application
• Exhibits48: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits49: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibits50: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
• Exhibits57: Data Table on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
• Exhibits58: Chart on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by Application ($ billion)
• Exhibits61: Data Table on Market opportunity by Application ($ billion)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ billion)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: Abcam plc - Overview
• Exhibits112: Abcam plc - Product / Service
• Exhibits113: Abcam plc - Key news
• Exhibits114: Abcam plc - Key offerings
• Exhibits115: Abnova Corp. - Overview
• Exhibits116: Abnova Corp. - Product / Service
• Exhibits117: Abnova Corp. - Key offerings
• Exhibits118: Bio Rad Laboratories Inc. - Overview
• Exhibits119: Bio Rad Laboratories Inc. - Business segments
• Exhibits120: Bio Rad Laboratories Inc. - Key news
• Exhibits121: Bio Rad Laboratories Inc. - Key offerings
• Exhibits122: Bio Rad Laboratories Inc. - Segment focus
• Exhibits123: BMG LABTECH GmbH - Overview
• Exhibits124: BMG LABTECH GmbH - Product / Service
• Exhibits125: BMG LABTECH GmbH - Key offerings
• Exhibits126: Cell Signaling Technology Inc. - Overview
• Exhibits127: Cell Signaling Technology Inc. - Product / Service
• Exhibits128: Cell Signaling Technology Inc. - Key offerings
• Exhibits129: Chemie Brunschwig AG - Overview
• Exhibits130: Chemie Brunschwig AG - Product / Service
• Exhibits131: Chemie Brunschwig AG - Key offerings
• Exhibits132: Elabscience Biotechnology Inc. - Overview
• Exhibits133: Elabscience Biotechnology Inc. - Product / Service
• Exhibits134: Elabscience Biotechnology Inc. - Key offerings
• Exhibits135: F. Hoffmann La Roche Ltd. - Overview
• Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits137: F. Hoffmann La Roche Ltd. - Key news
• Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits140: Fujirebio Holdings Inc. - Overview
• Exhibits141: Fujirebio Holdings Inc. - Product / Service
• Exhibits142: Fujirebio Holdings Inc. - Key offerings
• Exhibits143: GenScript Biotech Corp. - Overview
• Exhibits144: GenScript Biotech Corp. - Business segments
• Exhibits145: GenScript Biotech Corp. - Key news
• Exhibits146: GenScript Biotech Corp. - Key offerings
• Exhibits147: GenScript Biotech Corp. - Segment focus
• Exhibits148: Merck KGaA - Overview
• Exhibits149: Merck KGaA - Business segments
• Exhibits150: Merck KGaA - Key news
• Exhibits151: Merck KGaA - Key offerings
• Exhibits152: Merck KGaA - Segment focus
• Exhibits153: PerkinElmer Inc. - Overview
• Exhibits154: PerkinElmer Inc. - Business segments
• Exhibits155: PerkinElmer Inc. - Key news
• Exhibits156: PerkinElmer Inc. - Key offerings
• Exhibits157: PerkinElmer Inc. - Segment focus
• Exhibits158: Rockland Immunochemicals Inc. - Overview
• Exhibits159: Rockland Immunochemicals Inc. - Product / Service
• Exhibits160: Rockland Immunochemicals Inc. - Key offerings
• Exhibits161: Santa Cruz Biotechnology Inc. - Overview
• Exhibits162: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibits163: Santa Cruz Biotechnology Inc. - Key offerings
• Exhibits164: Thermo Fisher Scientific Inc. - Overview
• Exhibits165: Thermo Fisher Scientific Inc. - Business segments
• Exhibits166: Thermo Fisher Scientific Inc. - Key news
• Exhibits167: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits168: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits169: Inclusions checklist
• Exhibits170: Exclusions checklist
• Exhibits171: Currency conversion rates for US$
• Exhibits172: Research methodology
• Exhibits173: Validation techniques employed for market sizing
• Exhibits174: Information sources
• Exhibits175: List of abbreviations

Abstract

The neuroscience antibodies and assays market is forecasted to grow by USD 2.20 bn during 2023-2028, accelerating at a CAGR of 9.64% during the forecast period. The report on the neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidences of neurological disorders, increasing initiatives and support from governments and healthcare organizations, and technological advances in antibody manufacturing.

Technavio's neuroscience antibodies and assays market is segmented as below:

By Type

• Consumables
• Instruments

By Application

• Pharmaceutical and biopharmaceutical companies
• Academic and research institutes
• Hospital and diagnostic centers

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing clinical trials as one of the prime reasons driving the neuroscience antibodies and assays market growth during the next few years. Also, emergence of liquid biopsies and rising adoption of single-cell analysis techniques will lead to sizable demand in the market.

The report on the neuroscience antibodies and assays market covers the following areas:

• Neuroscience antibodies and assays market sizing
• Neuroscience antibodies and assays market forecast
• Neuroscience antibodies and assays market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuroscience antibodies and assays market vendors that include Abcam plc, Abnova Corp., Bio Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., GenScript Biotech Corp., Kaneka Corp., Merck KGaA, NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., and Thermo Fisher Scientific Inc.. Also, the neuroscience antibodies and assays market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global neuroscience antibodies and assays market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global neuroscience antibodies and assays market 2018 - 2022 ($ billion)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Consumables - Market size and forecast 2023-2028
• Exhibit 34: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Consumables - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
• 6.4 Instruments - Market size and forecast 2023-2028
• Exhibit 38: Chart on Instruments - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Instruments - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ billion)
• Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 44: Chart on Application - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 46: Chart on Comparison by Application
• Exhibit 47: Data Table on Comparison by Application
• 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
• Exhibit 48: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 49: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 50: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
• 7.4 Academic and research institutes - Market size and forecast 2023-2028
• Exhibit 52: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• 7.5 Hospital and diagnostic centers - Market size and forecast 2023-2028
• Exhibit 56: Chart on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Application
• Exhibit 60: Market opportunity by Application ($ billion)
• Exhibit 61: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 France - Market size and forecast 2023-2028
• Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Abcam plc
• Exhibit 111: Abcam plc - Overview
• Exhibit 112: Abcam plc - Product / Service
• Exhibit 113: Abcam plc - Key news
• Exhibit 114: Abcam plc - Key offerings
• 12.4 Abnova Corp.
• Exhibit 115: Abnova Corp. - Overview
• Exhibit 116: Abnova Corp. - Product / Service
• Exhibit 117: Abnova Corp. - Key offerings
• 12.5 Bio Rad Laboratories Inc.
• Exhibit 118: Bio Rad Laboratories Inc. - Overview
• Exhibit 119: Bio Rad Laboratories Inc. - Business segments
• Exhibit 120: Bio Rad Laboratories Inc. - Key news
• Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
• 12.6 BMG LABTECH GmbH
• Exhibit 123: BMG LABTECH GmbH - Overview
• Exhibit 124: BMG LABTECH GmbH - Product / Service
• Exhibit 125: BMG LABTECH GmbH - Key offerings
• 12.7 Cell Signaling Technology Inc.
• Exhibit 126: Cell Signaling Technology Inc. - Overview
• Exhibit 127: Cell Signaling Technology Inc. - Product / Service
• Exhibit 128: Cell Signaling Technology Inc. - Key offerings
• 12.8 Chemie Brunschwig AG
• Exhibit 129: Chemie Brunschwig AG - Overview
• Exhibit 130: Chemie Brunschwig AG - Product / Service
• Exhibit 131: Chemie Brunschwig AG - Key offerings
• 12.9 Elabscience Biotechnology Inc.
• Exhibit 132: Elabscience Biotechnology Inc. - Overview
• Exhibit 133: Elabscience Biotechnology Inc. - Product / Service
• Exhibit 134: Elabscience Biotechnology Inc. - Key offerings
• 12.10 F. Hoffmann La Roche Ltd.
• Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 Fujirebio Holdings Inc.
• Exhibit 140: Fujirebio Holdings Inc. - Overview
• Exhibit 141: Fujirebio Holdings Inc. - Product / Service
• Exhibit 142: Fujirebio Holdings Inc. - Key offerings
• 12.12 GenScript Biotech Corp.
• Exhibit 143: GenScript Biotech Corp. - Overview
• Exhibit 144: GenScript Biotech Corp. - Business segments
• Exhibit 145: GenScript Biotech Corp. - Key news
• Exhibit 146: GenScript Biotech Corp. - Key offerings
• Exhibit 147: GenScript Biotech Corp. - Segment focus
• 12.13 Merck KGaA
• Exhibit 148: Merck KGaA - Overview
• Exhibit 149: Merck KGaA - Business segments
• Exhibit 150: Merck KGaA - Key news
• Exhibit 151: Merck KGaA - Key offerings
• Exhibit 152: Merck KGaA - Segment focus
• 12.14 PerkinElmer Inc.
• Exhibit 153: PerkinElmer Inc. - Overview
• Exhibit 154: PerkinElmer Inc. - Business segments
• Exhibit 155: PerkinElmer Inc. - Key news
• Exhibit 156: PerkinElmer Inc. - Key offerings
• Exhibit 157: PerkinElmer Inc. - Segment focus
• 12.15 Rockland Immunochemicals Inc.
• Exhibit 158: Rockland Immunochemicals Inc. - Overview
• Exhibit 159: Rockland Immunochemicals Inc. - Product / Service
• Exhibit 160: Rockland Immunochemicals Inc. - Key offerings
• 12.16 Santa Cruz Biotechnology Inc.
• Exhibit 161: Santa Cruz Biotechnology Inc. - Overview
• Exhibit 162: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibit 163: Santa Cruz Biotechnology Inc. - Key offerings
• 12.17 Thermo Fisher Scientific Inc.
• Exhibit 164: Thermo Fisher Scientific Inc. - Overview
• Exhibit 165: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 166: Thermo Fisher Scientific Inc. - Key news
• Exhibit 167: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 168: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 171: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources
• 13.5 List of abbreviations
• Exhibit 175: List of abbreviations